|
| Secukinumab Basic information |
Product Name: | Secukinumab | Synonyms: | Secukinumab;Research Grade Secukinumab(DHH28802);AIN 457;AIN457;AIN-457;Secukinumab (anti-IL-17A) | CAS: | 1229022-83-6 | MF: | | MW: | 0 | EINECS: | | Product Categories: | | Mol File: | Mol File | |
| Secukinumab Chemical Properties |
form | Liquid | color | Colorless to light yellow | CAS DataBase Reference | 1229022-83-6 |
| Secukinumab Usage And Synthesis |
Clinical Use | Human IgG1/κ monoclonal antibody:
Treatment of moderate to severe plaque psoriasis,
psoriatic arthritis, ankylosing spondylitis | Drug interactions | Potentially hazardous interactions with other drugs
Vaccines: risk of generalised infections with live
vaccines - avoid. | Metabolism | The majority of IgG elimination occurs via intracellular
catabolism, following fluid-phase or receptor mediated
endocytosis. |
| Secukinumab Preparation Products And Raw materials |
|